Drug delivery in biotechnology: present and future

Drug delivery is becoming a whole interdisciplinary and independent field of research and is gaining the attention of pharmaceutical makers, medical doctors and industry. A targeted and safe drug delivery could improve the performance of some classical medicines already on the market and, moreover, will have implications for the development and success of new therapeutic strategies, such as peptide and protein delivery, glycoprotein administration, gene therapy and RNA interference. Many innovative technologies for effective drug delivery have been developed, including implants, nanotechnology, cell and peptide encapsulation, microfabrication, chemical modification and others. On the long way from the clinic to market, however, several issues will have to be addressed, including suitable scientific development, specific financial support as a result of altered scientific policy, government regulations and market forces.     

The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature

Looked at from the genetic point-of-view cancer represents a daunting and, frankly, confusing multiplicity of diseases (at least 100) that require an equally large variety of therapeutic strategies and substances designed to treat the particular tumor. However, when analyzed phenotypically cancer is a relatively uniform disease of very conserved 'hallmark' behaviors across the entire spectrum of tissue and genetic differences [D. Hanahan, R.A. Weinberg, Hallmarks of cancer, Cell 100 (2000) 57-70]. This suggests that cancers do, indeed, share common biochemical and physiological characteristics that are independent of the varied genetic backgrounds, and that there may be a common mechanism underlying both the neoplastic transformation/progression side and the antineoplastic/therapy side of oncology. The challenge of modern oncology is to integrate all the diverse experimental data to create a physiological/metabolic/energetic paradigm that can unite our thinking in order to understand how both neoplastic progression and therapies function. This reductionist view gives the hope that, as in chemistry and physics, it will possible to identify common underlying driving forces that define a tumor and will permit, for the first time, the actual calculated manipulation of their state. That is, a rational therapeutic design. In the present review, we present evidence, obtained from a great number of studies, for a fundamental, underlying mechanism involved in the initiation and evolution of the neoplastic process. There is an ever growing body of evidence that all the important neoplastic phenotypes are driven by an alkalization of the transformed cell, a process which seems specific for transformed cells since the same alkalinization has no effect in cells that have not been transformed. Seen in that light, different fields of cancer research, from etiopathogenesis, cancer cell metabolism and neovascularization, to multiple drug resistance (MDR), selective apoptosis, modern cancer chemotherapy and the spontaneous regression of cancer (SRC) all appear to have in common a pivotal characteristic, the aberrant regulation of hydrogen ion dynamics [S. Harguindey, J.L. Pedraz, R. García Ca?ero, J. Pérez de Diego, E.J. Cragoe Jr., Hydrogen ion-dependent oncogenesis and parallel new avenues to cancer prevention and treatment using a H+-mediated unifying approach: pH-related and pH-unrelated mechanisms, Crit. Rev. Oncog. 6 (1) (1995) 1-33]. Cancer cells have an acid-base disturbance that is completely different than observed in normal tissues and that increases in correspondence with increasing neoplastic state: an interstitial acid microenvironment linked to an intracellular alkalosis.     

The search for new beta-cell sources

Type 1 diabetes affects an estimated 150 million people worldwide and results from an autoimmune-mediated destruction of insulin-producing beta-cells. In the United States alone more than 16 million people are affected by this disease and it is estimated that spending for diabetes management accounts for one out of every eight healthcare dollars. In this context, scientists are proposing novel therapeutic strategies that might allow a perfect glycemic control of most patients with diabetes.     

Iron‐sulfur cluster carrier proteins involved in the assembly of Escherichia coli NADH:ubiquinone oxidoreductase (complex I)

The NADH:ubiquinone oxidoreductase (respiratory complex I) is the main entry point for electrons into the Escherichia coli aerobic respiratory chain. With its sophisticated setup of 13 different subunits and 10 cofactors, it is anticipated that various chaperones are needed for its proper maturation. However, very little is known about the assembly of E. coli complex I, especially concerning the incorporation of the iron‐sulfur clusters. To identify iron‐sulfur cluster carrier proteins possibly involved in the process, we generated knockout strains of NfuA, BolA, YajL, Mrp, GrxD and IbaG that have been reported either to be involved in the maturation of mitochondrial complex I or to exert influence on the clusters of bacterial complex. We determined the NADH and succinate oxidase activities of membranes from the mutant strains to monitor the specificity of the individual mutations for complex I. The deletion of NfuA, BolA and Mrp led to a decreased stability and partially disturbed assembly of the complex as determined by sucrose gradient centrifugation and native PAGE. EPR spectroscopy of cytoplasmic membranes revealed that the BolA deletion results in the loss of the binuclear Fe/S cluster N1b.     

Endophilin B1/Bif-1 Stimulates BAX Activation Independently from Its Capacity to Produce Large Scale Membrane Morphological Rearrangements

Endophilin B1/BAX-interacting factor 1 (Bif-1) is a protein that cooperates with dynamin-like protein 1 (DLP1/Drp1) to maintain normal mitochondrial outer membrane (MOM) dynamics in healthy cells and also contributes to BAX-driven MOM permeabilization (MOMP), the irreversible commitment point to cell death for the majority of apoptotic stimuli. However, despite its importance, exactly how Bif-1 fulfils its proapoptotic role is unknown. Here, we demonstrate that the stimulatory effect of Bif-1 on BAX-driven MOMP and on BAX conformational activation observed in intact cells during apoptosis can be recapitulated in a simplified system consisting of purified proteins and MOM-like liposomes. In this reconstituted model system the N-BAR domain of Bif-1 reproduced the stimulatory effect of Bif-1 on functional BAX activation. This process was dependent on physical interaction between Bif-1 N-BAR and BAX as well as on the presence of the mitochondrion-specific lipid cardiolipin. Despite that Bif-1 N-BAR produced large scale morphological rearrangements in MOM-like liposomes, this phenomenon could be separated from functional BAX activation. Furthermore, DLP1 also caused global morphological changes in MOM-like liposomes, but DLP1 did not stimulate BAX-permeabilizing function in the absence or presence of Bif-1. Taken together, our findings not only provide direct evidence for a functional interplay between Bif-1, BAX, and cardiolipin during MOMP but also add significantly to the growing body of evidence indicating that components of the mitochondrial morphogenesis machinery possess proapoptotic functions that are independent from their recognized roles in normal mitochondrial dynamics.MOMP³ is a key event in the intrinsic pathway of mammalian apoptosis, resulting in the release of several apoptogenic proteins from the mitochondrial intermembrane space into the cytosol (1). Released intraorganellar components, including cytochrome c, Smac/DIABLO, and AIF, then act as mediators for activating executioner caspase proteases or for other downstream events in the intracellular apoptosis cascade. MOMP is tightly regulated by BCL-2 family members, whose core components are proapoptotic BAX-type proteins that directly effect MOMP and antiapoptotic BCL-2-type proteins which inhibit MOMP (2, 3). In a currently popular model, a third subgroup of BCL-2 family proteins, the BH3-only proteins, trigger a set of conformational changes in BAX and/or its close homologue BAK that activates their permeabilizing function, thereby causing MOMP.Multiple proteins implicated in mitochondrial morphogenesis during normal growth conditions can cross-talk with BCL-2 family members to affect the mitochondrial pathway of apoptosis (4). For example, the large dynamin-like GTPase DLP1/Drp1 and hFis1, two essential components of the mitochondrial fission machinery, have been shown to modulate pro-apoptotic BAX function and mitochondrial cytochrome c release by acting at the level of the MOM (5–7). However, although excessive mitochondrial fragmentation is characteristic in mammalian apoptosis, controversy persists as to whether this phenomenon is merely coincident with or causatively linked to MOMP induction (4 – 8). In addition, a considerable body of evidence has amassed indicating that DLP1/Drp1 and hFis1 are multifunctional proteins that do not use the same mechanisms to reshape mitochondria in healthy conditions and to promote release of mitochondrial intermembrane space proteins during apoptosis (7–10).Endophilin B1/BAX-interacting factor 1 (Bif-1) is another protein linking mitochondrial morphological changes and BCL-2-regulated programmed cell death (4). On the one hand, Bif-1 is known to participate downstream of DLP1/Drp1, modulating normal MOM morphological dynamics in healthy cells (11). On the other hand, in response to specific apoptotic signals, a significant portion of Bif-1 binds BAX at the MOM in close temporal correlation with BAX conformational change and cytochrome c release (12). In addition, increasing the levels of Bif-1 has been shown to accelerate BAX conformational change, caspase activation, and apoptotic cell death, whereas loss of Bif-1 delays all these processes (12, 13). Together, these previous findings point to an important contributing role of Bif-1 in BAX-driven MOMP during apoptosis, but the underlying molecular mechanism remains unknown.As other members of the endophilin family, Bif-1 contains an N-BAR (Bin-amphiphysin-Rvs) domain that has been shown to confer ability to these proteins for transforming flat lipid bilayers into high curvature buds, tubules, and vesicles in vitro (14–17). Crystallographic studies of the N-BAR domain of endophilin A1, a close homologue of Bif-1, revealed a crescent-shape homodimer with a positively charged concave surface which is believed to act like a molecular scaffold that impresses its own curvature on binding to negatively charged membranes (16, 18). Another distinguishing feature of endophilin N-BAR domains is the presence of two distinct amphipathic segments referred to as “Helix 0” (H0) and “Helix 1 insert” (H1I) that penetrate only partway into the external leaflet and are thought to create a wedge effect that also increases membrane curvature. This dual curvature-generating mechanism has been linked to the shared capacity of endophilins to operate in membrane tubulovesicular dynamics during normal cell growth together with dynamin/dynamin-like proteins (16–18). However, exactly how the molecular-scale perturbation of membrane curvature induced by N-BAR domains translates into large scale membrane remodeling processes (e.g. tubulation and vesiculation) is not well understood (19–25). In addition, it is unclear whether the ability of Bif-1 to produce global changes in membrane morphology is functionally connected to its apoptotic mode of action.The complexity of the network of intermolecular interactions that controls the BCL-2-regulated MOMP pathway constitutes a major hurdle for gaining a molecular-level understanding of Bif-1 pro-death function in intact cells. Another complicating factor is that Bif-1 can interact with binding partners other than BAX at intracellular membranes distinct from the MOM depending on environmental conditions (14, 26–29). In previous studies this and other laboratories have shown that the BCL-2-regulated MOMP pathway can be reconstituted in a simplified system consisting of purified recombinant proteins and chemically defined MOM-like large unilamellar vesicles (LUV) in a manner that faithfully reflects the basic physiological functions of BCL-2 family proteins at the MOM (30–33). Here, we have used this minimal cell-free system to advance our understanding of the pro-death role of Bif-1. We provide strong evidence for a direct implication of Bif-1 in functional BAX activation at the membrane level and novel insights concerning the mechanism through which Bif-1 achieves this effect.     

Water use efficiency, transpiration and net CO2 exchange of four alfalfa genotypes submitted to progressive drought and subsequent recovery

The predicted worldwide increase in arid areas and water stress episodes will strongly affect crop production. Plants have developed a wide diversity of physiological mechanisms for drought tolerance. A decline in photosynthesis and thus yield production is a common response to drought, as are increases in the water use efficiency of photosynthesis (WUE_ph) and productivity (WUE_p). The aim of our study was to determine the physiological effects (especially WUE_ph and WUE_p) of progressive drought and subsequent recovery in three cultivars adapted to a Mediterranean climate [Tafilalet (TA), Tierra de Campos (TC), and Moapa (MO)], and another representative from an oceanic climate (Europe (EU)). The accuracy of the relationships between WUE_ph or WUE_p and carbon isotope discrimination (Δ ¹³C) in shoots was also investigated as a function of water stress intensity. Mild drought (7 days of water withholding) decreased the net CO₂ exchange (A), leaf conductance to water (g) and transpiration in EU leading to an increased WUE_ph. Δ ¹³C was correlated with WUE_p but not with WUE_ph, probably due to a late decrease in g. After moderate drought (14 days), A and g decreased in all cultivars, increasing WUE_ph. In this period WUE_p also increased. Both WUE parameters were correlated with Δ ¹³C, which may indicate that the g value at the end of moderate water stress was representative of the growing period. After 21 days, TA was the most productive cultivar but under severe drought conditions there was no difference in DM accumulation among cultivars. After the recovery period, leaf area was increased but not total DM, showing that leaves were the most responsive organs to rewatering. Severe water stress did not decrease WUE_ph or WUE_p, and Δ ¹³C did not increase after recovery. This absence of a response to severe drought may indicate significant effects on the photosynthetic apparatus after 21 days of withholding water. As for mild drought, WUE_p but not WUE_ph was correlated with Δ ¹³C, supporting the view that WUE_p is a more integrative parameter than WUE_ph.